首页> 美国卫生研究院文献>BMJ Open >REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre phase II open-label randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
【2h】

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre phase II open-label randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial

机译:肝硬化中STem细胞的自体重复输注(REALISTIC):一项多中心II期开放标签随机对照试验多次自体输注粒细胞集落刺激因子(GCSF)动员了CD133 +骨髓干细胞。随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionLiver disease mortality and morbidity are rapidly rising and liver transplantation is limited by organ availability. Small scale human studies have shown that stem cell therapy is safe and feasible and has suggested clinical benefit. No published studies have yet examined the effect of stem cell therapy in a randomised controlled trial and evaluated the effect of repeated therapy.
机译:简介肝脏疾病的死亡率和发病率正在迅速上升,肝脏移植受到器官可用性的限制。人体的小规模研究表明,干细胞治疗是安全可行的,并已表明其临床益处。尚无发表的研究在随机对照试验中检查干细胞治疗的效果并评估重复治疗的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号